227 related articles for article (PubMed ID: 19651633)
1. Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic.
Lao-Sirieix P; Boussioutas A; Kadri SR; O'Donovan M; Debiram I; Das M; Harihar L; Fitzgerald RC
Gut; 2009 Nov; 58(11):1451-9. PubMed ID: 19651633
[TBL] [Abstract][Full Text] [Related]
2. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
[TBL] [Abstract][Full Text] [Related]
3. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2.
Van De Bovenkamp JH; Korteland-Van Male AM; Warson C; Büller HA; Einerhand AW; Ectors NL; Dekker J
Histopathology; 2003 Jun; 42(6):555-65. PubMed ID: 12786891
[TBL] [Abstract][Full Text] [Related]
4. The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands.
Lavery DL; Nicholson AM; Poulsom R; Jeffery R; Hussain A; Gay LJ; Jankowski JA; Zeki SS; Barr H; Harrison R; Going J; Kadirkamanathan S; Davis P; Underwood T; Novelli MR; Rodriguez-Justo M; Shepherd N; Jansen M; Wright NA; McDonald SA
Gut; 2014 Dec; 63(12):1854-63. PubMed ID: 24550372
[TBL] [Abstract][Full Text] [Related]
5. Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.
Chettouh H; Mowforth O; Galeano-Dalmau N; Bezawada N; Ross-Innes C; MacRae S; Debiram-Beecham I; O'Donovan M; Fitzgerald RC
Gut; 2018 Nov; 67(11):1942-1949. PubMed ID: 29084829
[TBL] [Abstract][Full Text] [Related]
6. Molecular evaluation of ablative therapy of Barrett's oesophagus.
Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
[TBL] [Abstract][Full Text] [Related]
7. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa.
Going JJ; Keith WN; Neilson L; Stoeber K; Stuart RC; Williams GH
Gut; 2002 Mar; 50(3):373-7. PubMed ID: 11839717
[TBL] [Abstract][Full Text] [Related]
9. Trefoil Factor Expression in a Human Model of the Early Stages of Barrett's Esophagus.
Dunn LJ; Jankowski JA; Griffin SM
Dig Dis Sci; 2015 May; 60(5):1187-94. PubMed ID: 25424203
[TBL] [Abstract][Full Text] [Related]
10. Distribution of laminins in the basement membranes of the upper gastrointestinal tract and Barrett's oesophagus.
Dave U; Thursz MR; Ebrahim HY; Burke MM; Townsend ER; Walker MM
J Pathol; 2004 Mar; 202(3):299-304. PubMed ID: 14991894
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J
Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499
[TBL] [Abstract][Full Text] [Related]
12. Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo.
Obszynska JA; Atherfold PA; Nanji M; Glancy D; Santander S; Graham TA; Otto WR; West K; Harrison RF; Jankowski JA
Gut; 2010 Feb; 59(2):156-63. PubMed ID: 19651631
[TBL] [Abstract][Full Text] [Related]
13. Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.
Barclay JY; Morris A; Nwokolo CU
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):221-7. PubMed ID: 15674101
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus.
Labouvie C; Machado JC; Carneiro F; Sarbia M; Vieth M; Porschen R; Seitz G; Blin N
J Cancer Res Clin Oncol; 1999; 125(2):71-6. PubMed ID: 10190312
[TBL] [Abstract][Full Text] [Related]
15. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.
Lomo LC; Blount PL; Sanchez CA; Li X; Galipeau PC; Cowan DS; Ayub K; Rabinovitch PS; Reid BJ; Odze RD
Am J Surg Pathol; 2006 Apr; 30(4):423-35. PubMed ID: 16625087
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
[TBL] [Abstract][Full Text] [Related]
17. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
18. Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus.
Rajendra S; Ackroyd R; Karim N; Mohan C; Ho JJ; Kutty MK
J Clin Pathol; 2006 Sep; 59(9):952-7. PubMed ID: 16467164
[TBL] [Abstract][Full Text] [Related]
19. Extensive telomere erosion is consistent with localised clonal expansions in Barrett's metaplasia.
Letsolo BT; Jones RE; Rowson J; Grimstead JW; Keith WN; Jenkins GJ; Baird DM
PLoS One; 2017; 12(3):e0174833. PubMed ID: 28362812
[TBL] [Abstract][Full Text] [Related]
20. Barrett's oesophagus--a pathologist's view.
Fléjou JF; Svrcek M
Histopathology; 2007 Jan; 50(1):3-14. PubMed ID: 17204017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
